$3.25 Billion is the total value of Nantahala Capital Management's 111 reported holdings in Q2 2019. The portfolio turnover from Q1 2019 to Q2 2019 was 22.0% .
Value | Shares | ↓ Weighting | ||||||
---|---|---|---|---|---|---|---|---|
IWM | Sell | ISHARES TRput | $448,929,000 | -48.6% | 2,887,000 | -49.4% | 13.82% | -49.2% |
EXAS | EXACT SCIENCES CORPput | $153,003,000 | +36.3% | 1,296,200 | 0.0% | 4.71% | +34.6% | |
XLV | New | SELECT SECTOR SPDR TRput | $138,960,000 | – | 1,500,000 | +100.0% | 4.28% | – |
QURE | Buy | UNIQURE NVcall | $123,204,000 | +72.1% | 1,576,500 | +31.4% | 3.79% | +69.9% |
SGMS | Buy | SCIENTIFIC GAMES CORPcall | $118,730,000 | +4.5% | 5,990,400 | +7.6% | 3.66% | +3.1% |
ARQL | Sell | ARQULE INC | $114,453,000 | +99.0% | 10,395,405 | -13.4% | 3.52% | +96.5% |
QURE | Sell | UNIQURE NV | $112,728,000 | +24.4% | 1,442,460 | -5.0% | 3.47% | +22.9% |
WRLD | Sell | WORLD ACCEP CORP DEL | $101,329,000 | +33.5% | 617,446 | -4.7% | 3.12% | +31.8% |
CDXS | CODEXIS INC | $98,849,000 | -10.2% | 5,363,484 | 0.0% | 3.04% | -11.4% | |
XBI | Sell | SPDR SERIES TRUSTput | $97,928,000 | -38.2% | 1,116,500 | -36.2% | 3.02% | -39.0% |
CVNA | Buy | CARVANA COcall | $97,171,000 | +15.4% | 1,552,500 | +7.1% | 2.99% | +13.9% |
SPY | New | SPDR S&P 500 ETF TRput | $87,900,000 | – | 300,000 | +100.0% | 2.71% | – |
FCAU | Buy | FIAT CHRYSLER AUTOMOBILES Ncall | $80,432,000 | -4.5% | 5,820,000 | +2.6% | 2.48% | -5.7% |
RH | Buy | RH | $72,269,000 | +63.5% | 625,167 | +45.6% | 2.23% | +61.4% |
VAC | Buy | MARRIOTT VACTINS WORLDWID CO | $64,816,000 | +13.1% | 672,362 | +9.7% | 2.00% | +11.7% |
LXFR | LUXFER HOLDINGS PLC | $63,795,000 | -1.8% | 2,601,749 | 0.0% | 1.96% | -3.1% | |
AABA | Buy | ALTABA INC | $61,286,000 | -3.9% | 883,464 | +2.7% | 1.89% | -5.1% |
DXPE | Buy | DXP ENTERPRISES INC NEW | $54,165,000 | +10.1% | 1,429,545 | +13.1% | 1.67% | +8.7% |
THC | Buy | TENET HEALTHCARE CORPcall | $52,250,000 | -24.5% | 2,529,000 | +5.4% | 1.61% | -25.5% |
THC | Buy | TENET HEALTHCARE CORP | $51,070,000 | -16.5% | 2,471,914 | +16.5% | 1.57% | -17.6% |
CASH | META FINL GROUP INC | $50,482,000 | +42.5% | 1,799,727 | 0.0% | 1.56% | +40.7% | |
QADA | Buy | QAD INCcl a | $48,919,000 | +7.0% | 1,216,578 | +14.6% | 1.51% | +5.6% |
HCA | Buy | HCA HEALTHCARE INCput | $43,254,000 | +10.6% | 320,000 | +6.7% | 1.33% | +9.2% |
CVNA | Buy | CARVANA COcl a | $42,118,000 | +14.5% | 672,914 | +6.2% | 1.30% | +13.0% |
RH | Buy | RHcall | $41,558,000 | +20.7% | 359,500 | +7.5% | 1.28% | +19.2% |
IMXI | Sell | INTERNATIONAL MNY EXPRESS IN | $41,355,000 | +14.3% | 2,932,946 | -5.5% | 1.27% | +12.9% |
CZR | Buy | CAESARS ENTMT CORPcall | $39,372,000 | +60.0% | 3,331,000 | +17.7% | 1.21% | +58.0% |
GDEN | GOLDEN ENTMT INC | $34,296,000 | -1.1% | 2,449,713 | 0.0% | 1.06% | -2.4% | |
PRTY | Buy | PARTY CITY HOLDCO INC | $31,713,000 | +1.2% | 4,326,399 | +9.6% | 0.98% | -0.1% |
DLB | Buy | DOLBY LABORATORIES INC | $28,856,000 | +8.7% | 446,693 | +5.9% | 0.89% | +7.4% |
AKBA | Buy | AKEBIA THERAPEUTICS INC | $28,021,000 | -30.8% | 5,789,561 | +17.2% | 0.86% | -31.6% |
XELA | Buy | EXELA TECHNOLOGIES INC | $27,984,000 | -0.3% | 12,777,887 | +52.1% | 0.86% | -1.5% |
W | New | WAYFAIR INCcl a | $26,422,000 | – | 180,970 | +100.0% | 0.81% | – |
ONDK | Buy | ON DECK CAP INC | $26,206,000 | -6.4% | 6,314,703 | +22.3% | 0.81% | -7.6% |
TBBK | Buy | BANCORP INC DEL | $24,211,000 | +15.2% | 2,714,238 | +4.3% | 0.75% | +13.7% |
SGMS | Buy | SCIENTIFIC GAMES CORP | $23,780,000 | +37.4% | 1,199,785 | +41.5% | 0.73% | +35.6% |
SPB | Buy | SPECTRUM BRANDS HLDGS INC NE | $22,471,000 | +10.5% | 417,912 | +12.6% | 0.69% | +9.1% |
AFI | Buy | ARMSTRONG FLOORING INC | $21,319,000 | -22.8% | 2,164,349 | +6.6% | 0.66% | -23.7% |
BDSI | Buy | BIODELIVERY SCIENCES INTL IN | $21,321,000 | +47.1% | 4,585,267 | +67.6% | 0.66% | +45.4% |
AGLE | Buy | AEGLEA BIOTHERAPEUTICS INC | $19,538,000 | -8.5% | 2,852,260 | +7.5% | 0.60% | -9.6% |
ENT | Buy | GLOBAL EAGLE ENTMT INC | $19,558,000 | +212.0% | 28,835,876 | +226.3% | 0.60% | +208.7% |
CRHM | CRH MEDICAL CORP | $18,908,000 | +13.8% | 6,284,155 | 0.0% | 0.58% | +12.4% | |
CURO | Sell | CURO GROUP HLDGS CORP | $18,011,000 | -9.2% | 1,629,910 | -17.6% | 0.56% | -10.2% |
ESTA | Buy | ESTABLISHMENT LABS HLDGS INC | $17,429,000 | +14.7% | 792,604 | +25.4% | 0.54% | +13.3% |
DHX | DHI GROUP INC | $17,169,000 | +46.9% | 4,809,253 | 0.0% | 0.53% | +45.3% | |
Buy | FALCON MINERALS CORP | $16,950,000 | +33.2% | 2,017,894 | +40.2% | 0.52% | +31.5% | |
PAR | Buy | PAR TECHNOLOGY CORP | $16,928,000 | +25.8% | 600,299 | +9.1% | 0.52% | +24.0% |
JYNT | Sell | JOINT CORP | $16,121,000 | -10.1% | 885,769 | -22.2% | 0.50% | -11.3% |
RDNT | Buy | RADNET INC | $15,580,000 | +21.6% | 1,129,814 | +9.3% | 0.48% | +20.0% |
RFL | Sell | RAFAEL HLDGS INC | $13,954,000 | +61.1% | 485,366 | -29.1% | 0.43% | +59.3% |
HTZGQ | Buy | HERTZ GLOBAL HLDGS INCcall | $13,434,000 | -0.4% | 841,700 | +8.4% | 0.41% | -1.7% |
CUE | Buy | CUE BIOPHARMA INC | $12,390,000 | +82.5% | 1,378,198 | +57.0% | 0.38% | +80.2% |
SRL | New | SCULLY ROYALTY LTD | $11,167,000 | – | 839,654 | +100.0% | 0.34% | – |
SIGA | SIGA TECHNOLOGIES INC | $10,227,000 | -5.5% | 1,800,514 | 0.0% | 0.32% | -6.8% | |
AKBA | New | AKEBIA THERAPEUTICS INCcall | $9,680,000 | – | 2,000,000 | +100.0% | 0.30% | – |
FTACU | New | FINTECH ACQUISITION CORP IIIunit 12/01/2023 | $9,025,000 | – | 842,730 | +100.0% | 0.28% | – |
Buy | APTOSE BIOSCIENCES INC | $8,905,000 | +7024.0% | 3,412,042 | +5399.6% | 0.27% | +6750.0% | |
CBIO | Buy | CATALYST BIOSCIENCES INC | $7,686,000 | -1.1% | 1,042,843 | +8.8% | 0.24% | -2.1% |
SIC | Buy | SELECT INTERIOR CONCEPTS INCcl a | $7,613,000 | +1.6% | 653,461 | +8.6% | 0.23% | 0.0% |
CEMI | Buy | CHEMBIO DIAGNOSTICS INC | $7,551,000 | +18.3% | 1,239,983 | +7.8% | 0.23% | +17.1% |
RMBL | RUMBLEON INCcl b | $7,322,000 | -9.3% | 1,634,350 | 0.0% | 0.22% | -10.7% | |
SSKN | Buy | STRATA SKIN SCIENCES INC | $7,099,000 | -5.8% | 2,851,001 | +7.9% | 0.22% | -6.8% |
ELVT | Buy | ELEVATE CREDIT INC | $7,063,000 | +4.0% | 1,714,364 | +9.6% | 0.22% | +2.8% |
HTZGQ | Buy | HERTZ GLOBAL HLDGS INC | $7,022,000 | +1.1% | 440,000 | +10.0% | 0.22% | -0.5% |
PIRS | Buy | PIERIS PHARMACEUTICALS INC | $6,945,000 | +52.6% | 1,477,563 | +8.8% | 0.21% | +50.7% |
GLMD | Buy | GALMED PHARMACEUTICALS LTD | $6,559,000 | +1.0% | 879,200 | +10.6% | 0.20% | -0.5% |
TLYS | Buy | TILLYS INCcl a | $6,547,000 | -15.1% | 858,103 | +23.8% | 0.20% | -16.2% |
IGT | INTERNATIONAL GAME TECHNOLOGcall | $6,485,000 | -0.2% | 500,000 | 0.0% | 0.20% | -1.5% | |
TA | Buy | TRAVELCENTERS AMER LLC | $6,032,000 | +102.6% | 1,666,365 | +130.0% | 0.19% | +100.0% |
NEOS | Buy | NEOS THERAPEUTICS INC | $5,947,000 | -49.2% | 4,610,000 | +2.8% | 0.18% | -49.9% |
APEN | Sell | APOLLO ENDOSURGERY INC | $5,884,000 | -17.7% | 1,810,562 | -5.2% | 0.18% | -18.8% |
LINC | LINCOLN EDL SVCS CORP | $5,629,000 | -25.5% | 2,436,805 | 0.0% | 0.17% | -26.7% | |
NATR | NATURES SUNSHINE PRODUCTS IN | $5,511,000 | +1.7% | 583,510 | 0.0% | 0.17% | +0.6% | |
INSUU | INSURANCE ACQUISITION CORPunit 03/31/2024 | $5,175,000 | +2.5% | 500,000 | 0.0% | 0.16% | +0.6% | |
SHOS | SEARS HOMETOWN & OUTLET STOR | $5,084,000 | +12.0% | 2,136,251 | 0.0% | 0.16% | +10.6% | |
ARYAU | ARYA SCIENCES ACQUISITION COunit 10/04/2023 | $4,842,000 | +3.3% | 452,944 | 0.0% | 0.15% | +2.1% | |
GTTN | Sell | GTT COMMUNICATIONS INC | $4,353,000 | -80.6% | 235,486 | -63.7% | 0.13% | -80.9% |
MACK | New | MERRIMACK PHARMACEUTICALS IN | $3,918,000 | – | 647,635 | +100.0% | 0.12% | – |
ACER | Buy | ACER THERAPEUTICS INC | $3,864,000 | -82.0% | 990,655 | +12.0% | 0.12% | -82.2% |
EMMS | EMMIS COMMUNICATIONS CORP | $3,713,000 | +32.7% | 781,783 | 0.0% | 0.11% | +31.0% | |
DVD | DOVER MOTORSPORTS INC | $3,527,000 | +3.0% | 1,695,541 | 0.0% | 0.11% | +1.9% | |
ZVO | New | ZOVIO INC | $3,545,000 | – | 990,305 | +100.0% | 0.11% | – |
SCPL | New | SCIPLAY CORPcl a | $3,428,000 | – | 250,000 | +100.0% | 0.11% | – |
SNSS | New | SUNESIS PHARMACEUTICALS INC | $3,241,000 | – | 4,458,824 | +100.0% | 0.10% | – |
STRM | STREAMLINE HEALTH SOLUTIONS | $2,658,000 | +43.8% | 1,760,297 | 0.0% | 0.08% | +41.4% | |
VIVE | VIVEVE MED INC | $2,501,000 | -59.6% | 6,581,465 | 0.0% | 0.08% | -60.1% | |
DRIO | Buy | DARIOHEALTH CORP | $2,268,000 | -8.2% | 4,281,652 | +27.8% | 0.07% | -9.1% |
ASCMA | ASCENT CAP GROUP INC | $1,938,000 | +43.7% | 1,794,260 | 0.0% | 0.06% | +42.9% | |
MOTS | Sell | MOTUS GI HLDGS INC | $1,266,000 | -35.1% | 417,708 | -16.5% | 0.04% | -36.1% |
CHACU | CHARDAN HEALTHCARE ACQUISITIunit 12/13/2023 | $1,019,000 | +1.6% | 100,000 | 0.0% | 0.03% | 0.0% | |
HTZRT | New | HERTZ GLOBAL HLDGS INCright 07/12/2019 | $900,000 | – | 440,000 | +100.0% | 0.03% | – |
FALCON MINERALS CORP*w exp 07/21/202 | $834,000 | +14.4% | 878,022 | 0.0% | 0.03% | +13.0% | ||
RBCAA | REPUBLIC BANCORP KYcl a | $367,000 | +11.2% | 7,371 | 0.0% | 0.01% | +10.0% | |
FTDCQ | Exit | FTD COS INCcall | $0 | – | -250,000 | -100.0% | -0.00% | – |
KIRK | Exit | KIRKLANDS INCput | $0 | – | -100,000 | -100.0% | -0.02% | – |
FTDCQ | Exit | FTD COS INC | $0 | – | -3,710,763 | -100.0% | -0.06% | – |
IOVA | Exit | IOVANCE BIOTHERAPEUTICS INC | $0 | – | -238,945 | -100.0% | -0.07% | – |
RDNT | Exit | RADNET INCcall | $0 | – | -200,000 | -100.0% | -0.08% | – |
MFCB | Exit | MFC BANCORP LTD | $0 | – | -846,555 | -100.0% | -0.19% | – |
FTAC | Exit | FINTECH ACQUISITION CORP III | $0 | – | -842,730 | -100.0% | -0.27% | – |
RC | Exit | READY CAP CORP | $0 | – | -649,469 | -100.0% | -0.30% | – |
BPI | Exit | BRIDGEPOINT ED INC | $0 | – | -1,985,786 | -100.0% | -0.38% | – |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2019-08-14
About Nantahala Capital Management
Nantahala Capital Management is a hedge fund that was founded in 2004 by Wil Harkey. The firm is headquartered in Connecticut and has additional offices in New York and North Carolina. Nantahala Capital Management primarily invests in the technology, healthcare, and consumer sectors. The firm has a long-term investment approach and seeks to identify undervalued companies with strong growth potential.
Wil Harkey serves as the CEO and Chief Investment Officer of Nantahala Capital Management. He has over 20 years of experience in the finance industry and previously worked at Goldman Sachs and Maverick Capital. In addition to Harkey, the firm's leadership team includes COO and General Counsel, David Kozak, and CFO, Michael Kozak.
Nantahala Capital Management has a strong track record of generating positive returns for its investors. The firm's flagship fund, the Nantahala Fund, has delivered an annualized return of over 20% since its inception in 2006. The firm's success can be attributed to its disciplined investment approach and focus on long-term value creation.
Overall, Nantahala Capital Management is a well-respected hedge fund with a talented leadership team and a strong track record of performance. However, as with any investment, it is important for investors to conduct their own due diligence and carefully consider the risks before investing in the firm's funds.
It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.
Top long-term holdings
Name | Quarters owned | Latest quarter owned | Max weighting |
---|---|---|---|
ISHARES TR | 42 | Q3 2023 | 27.2% |
CODEXIS INC | 42 | Q3 2023 | 3.9% |
PATHWARD FINANCIAL INC | 35 | Q3 2023 | 6.3% |
SCIENTIFIC GAMES CORP | 34 | Q3 2022 | 5.3% |
DOVER MOTORSPORTS INC | 34 | Q3 2021 | 0.5% |
GOLDEN ENTMT INC | 33 | Q3 2023 | 2.1% |
QAD INC | 32 | Q3 2021 | 2.6% |
SCIENTIFIC GAMES CORP | 31 | Q4 2021 | 7.7% |
DOLBY LABORATORIES INC | 31 | Q4 2020 | 5.6% |
LINCOLN EDL SVCS CORP | 31 | Q4 2021 | 0.7% |
View Nantahala Capital Management's complete holdings history.
Latest significant ownerships (13-D/G)
Filed | Shares | Percentage | |
---|---|---|---|
AYTU BIOPHARMA, INC | June 16, 2023 | 1,086,812 | 19.7% |
Acer Therapeutics Inc. | February 14, 2023 | 1,226,191 | 7.5% |
Aeglea BioTherapeutics, Inc. | February 14, 2023 | 4,611,302 | 7.5% |
AKUMIN INC. | February 14, 2023 | 2,206,960 | 2.5% |
ALTA EQUIPMENT GROUP INC. | February 14, 2023 | 1,188,985 | 3.7% |
Apollo Endosurgery, Inc. | February 14, 2023 | 4,056,627 | 9.9% |
Autolus Therapeutics plc | February 14, 2023 | 7,782,018 | 4.7% |
Bioventus Inc. | February 14, 2023 | 3,168,574 | 5.1% |
CATALYST BIOSCIENCES, INC. | February 14, 2023 | 438,055 | 1.4% |
Drive Shack Inc. | February 14, 2023 | 6,500,000 | 7.0% |
View Nantahala Capital Management's complete significant-ownership history.
Latest filings
Type | Filed |
---|---|
4 | 2024-03-21 |
4 | 2024-03-15 |
SC 13G | 2024-03-11 |
13F-HR/A | 2024-02-15 |
13F-HR | 2024-02-14 |
SC 13G/A | 2024-02-14 |
SC 13G/A | 2024-02-14 |
SC 13G/A | 2024-02-14 |
SC 13G/A | 2024-02-14 |
SC 13G/A | 2024-02-14 |
View Nantahala Capital Management's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.